These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 21945185)
1. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Qin Y; Chen H; Zhang Q; Wang X; Yuan W; Kuai R; Tang J; Zhang L; Zhang Z; Zhang Q; Liu J; He Q Int J Pharm; 2011 Nov; 420(2):304-12. PubMed ID: 21945185 [TBL] [Abstract][Full Text] [Related]
2. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939 [TBL] [Abstract][Full Text] [Related]
4. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
5. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
6. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
7. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948 [TBL] [Abstract][Full Text] [Related]
8. Comparison of four different peptides to enhance accumulation of liposomes into the brain. Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model. Aoki H; Kakinuma K; Morita K; Kato M; Uzuka T; Igor G; Takahashi H; Tanaka R Int J Hyperthermia; 2004 Sep; 20(6):595-605. PubMed ID: 15370816 [TBL] [Abstract][Full Text] [Related]
10. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333 [TBL] [Abstract][Full Text] [Related]
11. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423 [TBL] [Abstract][Full Text] [Related]
12. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677 [TBL] [Abstract][Full Text] [Related]
13. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475 [TBL] [Abstract][Full Text] [Related]
14. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502 [TBL] [Abstract][Full Text] [Related]
15. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma. Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513 [TBL] [Abstract][Full Text] [Related]
16. Intracellular drug delivery by sulfatide-mediated liposomes to gliomas. Shao K; Hou Q; Duan W; Go ML; Wong KP; Li QT J Control Release; 2006 Oct; 115(2):150-7. PubMed ID: 16963144 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367 [TBL] [Abstract][Full Text] [Related]
18. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288 [TBL] [Abstract][Full Text] [Related]
19. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Tian W; Ying X; Du J; Guo J; Men Y; Zhang Y; Li RJ; Yao HJ; Lou JN; Zhang LR; Lu WL Eur J Pharm Sci; 2010 Oct; 41(2):232-43. PubMed ID: 20600880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]